Astrana Health (ASTH) vs Kforce (KFRC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Kforce (KFRC) has outperformed Astrana Health (ASTH) over the past year, gaining 75.8% versus a gain of 16.7%. Over five years, KFRC leads with a -18.7% price change compared with -49.8% for ASTH. Astrana Health is the larger company by market cap ($1.78 billion vs $937.5 million), about 1.9 times the size.
On valuation, Astrana Health trades at a lower forward P/E (9.9x vs 17.0x for Kforce). Kforce pays a dividend yielding 3.02%, while Astrana Health does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASTH | KFRC |
|---|---|---|
| Share price | $35.87 | $52.35 |
| Market cap | $1.78B | $937.54M |
| 1-day change | -3.42% | +1.18% |
| YTD return | +44.58% | +69.31% |
| 1-year return | +16.73% | +75.85% |
| 5-year return | -49.83% | -18.69% |
| P/E ratio (TTM) | 43.22 | 24.69 |
| Forward P/E | 9.86 | 16.95 |
| EPS (TTM) | $0.83 | $2.12 |
| Dividend yield | 0.00% | 3.02% |
| Annual dividend | $0.00 | $1.58 |
| 52-week high | $51.60 | $61.68 |
| 52-week low | $18.08 | $24.49 |
| Distance from 52-week high | -30.48% | -15.13% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +44.05% | +15.89% |
| Average volume | 462.64K | 256.46K |
| Shares outstanding | 49.60M | 17.91M |
| Employees | 3,000 | 1,600 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Professional Services | Professional Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- KFRC has outperformed ASTH by 59.1 percentage points over the past year.
- Astrana Health trades at a higher earnings multiple (43.2x vs 24.7x trailing P/E).
- Kforce offers a meaningfully higher dividend yield (3.02% vs 0.00%).
About Astrana Health
ASTH stock →Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.
Consumer Discretionary · Professional Services · 3,000 employees
About Kforce
KFRC stock →Kforce Inc. provides professional staffing services and solutions in the United States.
Consumer Discretionary · Professional Services · 1,600 employees
ASTH vs KFRC FAQ
Which is bigger, Astrana Health or Kforce?
Astrana Health (ASTH) is larger, with a market capitalization of $1.78B compared with $937.54M for Kforce (KFRC).
Which stock has performed better over the past year, ASTH or KFRC?
KFRC returned +75.85% over the past 12 months, compared with +16.73% for ASTH (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ASTH or KFRC?
KFRC has the lower trailing P/E at 24.7, versus 43.2 for ASTH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Astrana Health or Kforce?
Kforce pays a dividend yielding 3.02%, while Astrana Health does not currently pay a regular dividend.
Are Astrana Health and Kforce in the same industry?
Yes. Both are classified in the Professional Services industry within the Consumer Discretionary sector.